Injection pens for the weight-loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, on Tuesday, June 24, 2025. Novo Nordisk said it will sell its blockbuster weight-loss treatment Wegovy in India starting at $50 a week, tailoring the price to match the pocket of consumers in a nation with the world's third-largest obese population. Photographer: Dhiraj Singh/Bloomberg via Getty Images
